Multiple Sclerosis Clinical Trial

Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACELâ„¢ Vaccine

Summary

To further characterize the vaccine safety profile and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.

View Full Description

Full Description

Surveillance using a healthcare organization with large comprehensive medical encounter databases will be used in this study to identify any risks or uncommon events associated with use of the recently licensed Adacel vaccine that may occur in routine clinical usage in a large population.

No investigational vaccines will be administered in this study. Participants will be included in the study on the basis of their having received Adacel vaccine as part of routine care.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Receipt of ADACEL vaccine during the study period

Exclusion Criteria:

None

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

327293

Study ID:

NCT00258882

Recruitment Status:

Completed

Sponsor:

Sanofi Pasteur, a Sanofi Company

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You


Oakland California, , United States

Aurora Colorado, , United States

Portland Oregon, , United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

327293

Study ID:

NCT00258882

Recruitment Status:

Completed

Sponsor:


Sanofi Pasteur, a Sanofi Company

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider